Banque Pictet & Cie SA Has $9.53 Million Position in Humana Inc. (NYSE:HUM)

Banque Pictet & Cie SA grew its position in Humana Inc. (NYSE:HUM) by 114.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 37,541 shares of the insurance provider’s stock after buying an additional 20,031 shares during the quarter. Banque Pictet & Cie SA’s holdings in Humana were worth $9,525,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. FNY Investment Advisers LLC boosted its holdings in shares of Humana by 6,647.5% during the 4th quarter. FNY Investment Advisers LLC now owns 27,260 shares of the insurance provider’s stock valued at $6,916,000 after acquiring an additional 26,856 shares in the last quarter. Retirement Systems of Alabama boosted its stake in shares of Humana by 735.9% during the fourth quarter. Retirement Systems of Alabama now owns 219,002 shares of the insurance provider’s stock valued at $55,563,000 after purchasing an additional 192,801 shares in the last quarter. PDT Partners LLC grew its holdings in shares of Humana by 190.0% during the third quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider’s stock worth $1,286,000 after purchasing an additional 2,660 shares during the last quarter. Secure Asset Management LLC acquired a new position in shares of Humana in the fourth quarter valued at approximately $244,000. Finally, Ontario Teachers Pension Plan Board raised its holdings in Humana by 6.5% in the 3rd quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock valued at $371,705,000 after buying an additional 71,910 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors.

Humana Stock Performance

Shares of HUM stock opened at $252.92 on Friday. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. The firm has a 50-day moving average of $272.44 and a 200-day moving average of $295.47. Humana Inc. has a one year low of $213.31 and a one year high of $406.46. The company has a market cap of $30.45 billion, a P/E ratio of 22.40, a P/E/G ratio of 2.11 and a beta of 0.56.

Humana (NYSE:HUM) last posted its earnings results on Tuesday, February 11th. The insurance provider reported ($2.16) EPS for the quarter, topping the consensus estimate of ($2.26) by $0.10. Humana had a net margin of 1.18% and a return on equity of 13.20%. Equities research analysts forecast that Humana Inc. will post 16.11 EPS for the current fiscal year.

Wall Street Analyst Weigh In

HUM has been the topic of a number of research reports. Barclays boosted their target price on shares of Humana from $255.00 to $270.00 and gave the stock an “equal weight” rating in a report on Thursday. Cantor Fitzgerald reissued a “neutral” rating and issued a $290.00 price objective on shares of Humana in a research note on Wednesday. TD Cowen raised their target price on Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a research report on Monday, November 4th. Bank of America upgraded Humana from an “underperform” rating to a “neutral” rating and upped their price target for the company from $247.00 to $308.00 in a research report on Wednesday, November 6th. Finally, Wells Fargo & Company lowered their price objective on Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a research report on Monday, November 4th. Nineteen analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $293.05.

Insiders Place Their Bets

In other news, insider Timothy S. Huval sold 3,703 shares of the stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the transaction, the insider now owns 8,181 shares in the company, valued at approximately $2,096,463.06. This represents a 31.16 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Insiders own 0.32% of the company’s stock.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.